Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
El segmento de ingresos más grande es Ampio Pharmaceuticals Inc, con unos ingresos de Thermal Decomposition Process Oil en el último informe de ganancias. En cuanto a la geografía, Canada es el mercado principal para Ampio Pharmaceuticals Inc, con unos ingresos de 334,211.